Description
Ischaemic stroke results from occlusion of the cerebral circulation. Clot removal has been shown to be effective in reducing disability associated with large vessel occlusion. The optimal management of clot resulting from medium vessel occlusion is still unclear. It is uncertain if clot removal or clot busting drug is the best treatment. There are several trials evaluating this treatment including the Frontier AP trial. This trial has received funding from NHMRC Clinical Trial Cohort Grant ID 2032420.
The project available is suitable for neurology/geriatrician/rehabilitation trainee or specialist wishing to undertake PhD study. This will involve learning multivariate methods to relate anatomical location of infarct to stroke deficit and disability.
Examples of related material can be found at https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2020.00773/full and https://www.ahajournals.org/doi/abs/10.1161/STROKEAHA.123.046083
The project can be tailor made depending on the medical specialty interest of the candidate. One angle can be post-stroke cognitive dysfunction, post-stroke delirium, precision medicine approach to rehabilitation.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
stroke, medium vessel occlusion, mapping
School
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research
Available options
PhD/Doctorate
Time commitment
Full-time
Top-up scholarship funding available
No
Physical location
Monash Medical Centre Clayton
Co-supervisors
Prof
Henry Ma